而五和博澳目前锚定约40亿元估值。若以其2025年前九个月2.08亿元的营收推算，其市销率或远超荣昌生物等成熟Biotech的6-8倍区间，甚至显著高于信达生物与康方生物的行业标杆水平。
The astronaut who experienced a medical issue in space last month has identified himself as the sick member of his crew prompting an evacuation from the International Space Station.
，更多细节参见51吃瓜
09:36, 28 февраля 2026Россия
Opens in a new window